关键信息
-
基因名
GSDMC
- 应用
-
别名
GSDMC；MLZE；Gasdermin-C
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9BYG8
-
表达区间
1-508aa
-
氨基酸序列
MPSMLERISKNLVKEIGSKDLTPVKYLLSATKLRQFVILRKKKDSRSSFWEQSDYVPVEFSLNDILEPSSSVLETVVTGPFHFSDIMIQKHKADMGVNVGIEVSVSGEASVDHGCSLEFQIVTIPSPNLEDFQKRKLLDPEPSFLKECRRRGDNLYVVTEAVELINNTVLYDSSSVNILGKIALWITYGKGQGQGESLRVKKKALTLQKGMVMAYKRKQLVIKEKAILISDDDEQRTFQDEYEISEMVGYCAARSEGLLPSFHTISPTLFNASSNDMKLKPELFLTQQFLSGHLPKYEQVHILPVGRIEEPFWQNFKHLQEEVFQKIKTLAQLSKDVQDVMFYSILAMLRDRGALQDLMNMLELDSSGHLDGPGGAILKKLQQDSNHAWFNPKDPILYLLEAIMVLSDFQHDLLACSMEKRILLQQQELVRSILEPNFRYPWSIPFTLKPELLAPLQSEGLAITYGLLEECGLRMELDNPRSTWDVEAKMPLSALYGTLSLLQQLAEA
-
分子量
73.7 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
质检流程
相关产品
背景信息
The GSDMC (Gasdermin C) protein is part of the gasdermin family, which is known for its role in regulating pyroptosis, a form of programmed cell death associated with inflammatory responses. Emerging research has highlighted GSDMC's potential involvement in various physiological and pathological processes, including immunity, cancer, and neurodegenerative diseases. Understanding the structure and function of GSDMC can provide insights into its mechanism of action and how it interacts with other cellular components. Recent studies have focused on the recombinant expression of GSDMC to elucidate its functional properties, as well as to explore its potential as a therapeutic target. By generating recombinant GSDMC, researchers aim to characterize its pore-forming activity, assess its role in inflammatory signaling pathways, and investigate how it may promote or inhibit tumor progression. As such, GSDMC has garnered attention for its possible implications in disease mechanisms, offering a promising avenue for the development of novel therapeutic strategies aimed at modulating pyroptosis and related inflammatory processes. This growing interest in GSDMC underscores the need for further exploration of its biochemical characteristics and therapeutic potential, paving the way for innovative approaches to combat inflammation and cancer.
